Amersham Biosciences Selects MatrixOne to Manage Global Intellectual Capital.

Business/Technology Editors

WESTFORD, Mass.--(BUSINESS WIRE)--Feb. 12, 2002

Technia AB, MatrixOne's Partner in the Nordic Region of Europe, to

Develop and Deploy Amersham Biosciences' Collaboration Solution

MatrixOne, Inc. (NASDAQ: MONE), a leading provider of product collaboration solutions for the value chain, today announced that Amersham Biosciences has selected MatrixOne solutions to unify and support their product development processes in R&D and manufacturing engineering, as well as to streamline product information management. MatrixOne's partner in the Nordic region of Europe, Technia AB, was chosen to support the initiative to manage some of Amersham Biosciences' global intellectual capital.

In addition to deploying MatrixOne's eMatrix(TM) product collaboration platform, the agreement includes the implementation of Engineering Central, one of the out-of-the-box applications in the MatrixOne Value Chain Portfolio(TM). Engineering Central(TM) dramatically accelerates the ability of companies to implement engineering best practices across global value chains for product definition, bill of material (BOM) creation and management and engineering change. Amersham Biosciences will replace its current Product Data Management (PDM) system with Engineering Central in order to facilitate the development of instruments, software, and chemical reagents in biotechnological research and manufacture.

"The value of information is proportional to its availability," said Bengt-Ake Nilsson, vice president of information management at Amersham Biosciences. "This project will assist us to face future challenges and keep us ahead of our competition in the ever-faster moving Biotech market. Realizing the 'develop anywhere and produce anywhere' paradigm is very important to achieve the flexibility needed to be a leader in this dynamic business space."

Technia and eMatrix were selected after a careful six-month analysis and in competition with all major global PDM-suppliers. The decision was based on both companies' good track record and proven implementation methodology. Another factor was that Technia supplied a dedicated team of consultants with long industrial experience and ability to quickly understand Amersham Biosciences' business needs.

"We're pleased to have been engaged by Amersham Biosciences to implement the eMatrix solution," said Staffan Hanstorp, president, Technia AB. "This awarding of contract is a manifestation of Technia's strong commitment to its customers. We are committed to delivering a platform enabling better lifecycle profits for Amersham. I am convinced that Amersham Biosciences will succeed in achieving fast and real business benefits."

About Amersham Biosciences

Amersham Biosciences, the life sciences business of Amersham plc (LSE, NYE, OSE: AHM), is a world leader in developing and providing integrated systems and solutions for disease research, drug development and manufacture. Our systems are used to uncover the function of genes and proteins, for the discovery and development of drugs and for the manufacture of biopharmaceuticals. The customers for Amersham Biosciences' products and technologies are pharmaceutical and biotechnology companies and research and academic institutions, principally in North America, Europe, Latin America and Asia. For more information about Amersham Biosciences, please visit our web site at www.amershambiosciences.com.

About Technia AB

Technia is the leading supplier of Business Collaboration Solutions for creating and managing product information throughout the entire product lifecycle to the Nordic industry.Technia works with more than 200 Nordic companies. The company is established in Stockholm, Helsingfors and Oslo. Technia's customer list includes: Allgon, Amersham Biosciences, BT Products, Datex-Ohmeda, Ericsson, Elcoteq, ESAB, MacGregor Cranes, Nokia, Sweden Post, Scania, Seco Tools, Thorsman & Co., Valmet Corporation, Wallac. For more information about Technia, please visit our homepage www.technia.com.

About MatrixOne

MatrixOne, Inc. (NASDAQ: MONE) is changing the way the world brings products to market(TM). The Company's eMatrix(TM) product collaboration platform and out-of-the-box Value Chain Portfolio(TM) applications enable online collaboration across global value chains and secure access to independent trading communities in private and public marketplaces. A trusted partner to innovative companies, MatrixOne helps customers accelerate the right products to market. MatrixOne's approximately 600 global customers represent the aerospace/defense, apparel, automotive, consumer packaged goods, general machinery, high-technology, and life sciences industries, including GE, Procter & Gamble, Nokia, Siemens, JDS Uniphase, and Honda. Headquartered in Westford, Massachusetts, MatrixOne (www.MatrixOne.com) also maintains offices in North America, Europe, and Asia, with additional distributors in Latin America and Australia. MatrixOne and Adaplets are registered trademarks, and eMatrix, Changing the Way the World Brings Products to Market, Leading Provider of Product Collaboration for the Value Chain, and Value Chain Portfolio are trademarks of MatrixOne, Inc. All other trademarks and service marks are the property of their respective owners.

Forward-looking statements in this release are subject to risks and uncertainties that could cause our actual results to differ materially from those anticipated. Such statements may relate, among other things, to our plans, objectives and expected financial and operating results. The risks and uncertainties that may affect forward-looking statements include, among others: poor product sales, long sales cycles, difficulty developing new products, difficulty in relationships with vendors and partners, higher risk in international operations, difficulty assimilating future acquisitions, difficulty managing rapid growth, and increased competition. For a more about the risks and uncertainties of our business, see our periodic and other S.E.C. filings.